Cargando…
Nerve Growth Factor Gene Therapy Using Adeno-Associated Viral Vectors Prevents Cardiomyopathy in Type 1 Diabetic Mice
Diabetes is a cause of cardiac dysfunction, reduced myocardial perfusion, and ultimately heart failure. Nerve growth factor (NGF) exerts protective effects on the cardiovascular system. This study investigated whether NGF gene transfer can prevent diabetic cardiomyopathy in mice. We worked with mice...
Autores principales: | Meloni, Marco, Descamps, Betty, Caporali, Andrea, Zentilin, Lorena, Floris, Ilaria, Giacca, Mauro, Emanueli, Costanza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237667/ https://www.ncbi.nlm.nih.gov/pubmed/22187379 http://dx.doi.org/10.2337/db11-0763 |
Ejemplares similares
-
Capsid protein expression and adeno-associated virus like particles assembly in Saccharomyces cerevisiae
por: Backovic, Ana, et al.
Publicado: (2012) -
Adeno-associated viral (AAV) vector-mediated therapeutics for diabetic cardiomyopathy – current and future perspectives
por: Prakoso, Darnel, et al.
Publicado: (2021) -
EZH2 Modulates Angiogenesis In Vitro and in a Mouse Model of Limb Ischemia
por: Mitić, Tijana, et al.
Publicado: (2015) -
Adeno-Associated Viral Vectors in Neuroscience Research
por: Haggerty, David L., et al.
Publicado: (2019) -
Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia
por: Jazwa, Agnieszka, et al.
Publicado: (2013)